-
Story /Among the many Syrians uprooted by armed conflict are thousands of people with chronic conditions – such as diabetes and heart disease - whose treatment was disrupted when they fled.
-
Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
-
Story /Spinal muscular atrophy (SMA) is the most common genetic casue of infant and toddler death. NIBR scientists are trying to make a back up gene take up the slack.
-
Story /Novartis researchers are partnering with advocacy groups to understand the stigma and challenges facing patients with obesity.
-
Story /An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
-
Story / -
Story /Compound offers a potential tool for fighting drug-resistant malaria parasites.
-
Story /New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.
-
Story /Jennifer Leeds offers a behind-the-scenes look at the consortia forming to address COVID-19.
-
Story /Functional genomics study reveals a potential approach for tackling glioblastoma, pancreatic cancer and other tumors.
Pagination
- ‹ Previous page
- 1
- …
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- …
- 278
- › Next page